AAADV LOGO

Join us November 5โ€“6, 2026 in Bethesda, MD โ€” in-person and virtual.

Shaping the future of oncology drug development.

A 501(c)(3) nonprofit convening clinical investigators, regulators, industry leaders, biostatisticians, and patient advocates. Now in its third decade โ€” one of the field's most influential global forums.

2026

Annual
Workshop

November 5โ€“6

North Bethesda Marriott Hotel & Conference Center ยท Bethesda, MD

Dates

Nov 5โ€“6, 2026

Location

North Bethesda, MD

Format

In-Person & Virtual

Featured Keynote Speakers

The voices defining the regulatory landscape.

Five distinguished leaders headline the 2026 program, bringing decades of experience across the FDA, the National Academy of Medicine, and the investment community.

Richard Pazdur, MD

Richard Pazdur, MD

Former Director, FDA Oncology Center of Excellence

Robert Califf, MD

Robert Califf, MD

Former Commissioner, U.S. Food and Drug Administration

Peter Marks, MD, PhD

Peter Marks, MD, PhD

Former Director, FDA Center for Biologics Evaluation and Research

Monica Bertagnolli, MD

Monica Bertagnolli, MD

President, National Academy of Medicine

Thomas G. Roberts, Jr., MD

Thomas G. Roberts, Jr., MD

Vice Chair, Farallon Capital Management

Reserve your place at the 2026 Workshop.

Reserve your place at the 2026 Workshop.

Join the field's leading regulators, investigators, and patient advocates โ€” in person at the North Bethesda Marriott or via the live virtual broadcast.

In-Person Registration

Full two-day access in Bethesda, MD, including all sessions and networking.

Virtual Attendance

Stream every keynote and session live from anywhere in the world.

Continuing Education

Sessions structured around defined educational objectives for each topic.